Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF708 vs Forteo in Osteoporosis
NCT03002428Phase 3Completed
- Sponsor
- Pfenex Inc.
- Start
- Dec 2016
- Primary completion
- May 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of teriparatide in osteoporosis, sponsored by Pfenex Inc.. Started Dec 2016; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT03002428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03002428.